CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 195 filers reported holding CYTOKINETICS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $447,969 | +35.0% | 15,206 | +49.5% | 0.00% | +100.0% |
| Q2 2023 | $331,778 | -7.5% | 10,171 | -0.2% | 0.00% | -50.0% |
| Q1 2023 | $358,551 | -28.1% | 10,189 | -6.3% | 0.00% | -33.3% |
| Q4 2022 | $498,339 | +146.7% | 10,876 | +160.4% | 0.00% | +200.0% |
| Q3 2022 | $202,000 | +32.9% | 4,177 | +7.8% | 0.00% | 0.0% |
| Q2 2022 | $152,000 | +5.6% | 3,873 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $144,000 | +45.5% | 3,910 | +79.8% | 0.00% | 0.0% |
| Q4 2021 | $99,000 | +28.6% | 2,175 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $77,000 | +83.3% | 2,157 | +2.0% | 0.00% | – |
| Q2 2021 | $42,000 | -16.0% | 2,114 | -0.8% | 0.00% | -100.0% |
| Q1 2021 | $50,000 | +1566.7% | 2,131 | +1422.1% | 0.00% | – |
| Q4 2020 | $3,000 | -66.7% | 140 | -65.0% | 0.00% | – |
| Q3 2020 | $9,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,723,170 | $13,940,000 | 5.01% |
| RP Management, LLC | 875,656 | $7,084,000 | 3.54% |
| BVF INC/IL | 3,801,817 | $30,757,000 | 3.44% |
| DAFNA Capital Management LLC | 400,294 | $3,238,000 | 1.40% |
| Virtus ETF Advisers LLC | 33,758 | $273,000 | 0.58% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 67,352 | $545,000 | 0.44% |
| WASATCH ADVISORS LP | 3,188,487 | $25,795,000 | 0.28% |
| LANSDOWNE PARTNERS (UK) LLP | 1,459,706 | $11,809,000 | 0.26% |
| Campbell & CO Investment Adviser LLC | 43,844 | $355,000 | 0.18% |
| Fosun International Ltd | 239,792 | $1,981,000 | 0.13% |